Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000312069-25-000582·BARCLAYS PLC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
COMMON-STOCK · CUSIP: 46333X108
Event date: 2025-09-30
- Filing-level shares
- 3,167,713
- Percent of class
- 1.95%
- Barclays PLC
Shares: 3,167,713 · Class: 1.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000312069-25-000582
- Form type
- SCHEDULE 13G/A
- Filer
- BARCLAYS PLC
- CIK
- CIK 312069
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership